{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:01:13Z","timestamp":1786114873876,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["brainanddevelopment.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.braindev.2026.104563","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T11:53:43Z","timestamp":1781956423000},"page":"104563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Urine protein\/osmolality and creatinine\/osmolality ratios for assessing proteinuria and motor function in children with spinal muscular atrophy"],"prefix":"10.1016","volume":"48","author":[{"given":"H\u00fcseyin Bahad\u0131r","family":"\u015eenol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizem","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezgi","family":"\u00c7a\u011flar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"K\u00f6m\u00fcr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizem","family":"Do\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamze Sar\u0131kaya","family":"Uzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe \u0130pek","family":"Polat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adem","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe Semra","family":"H\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper","family":"Soylu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulu\u00e7","family":"Yi\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.braindev.2026.104563_bb0005","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1474-4422(12)70061-3","article-title":"Childhood spinal muscular atrophy: controversies and challenges","volume":"11","author":"Mercuri","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.braindev.2026.104563_bb0010","doi-asserted-by":"crossref","first-page":"100862","DOI":"10.1016\/j.lanepe.2024.100862","article-title":"Petri S, et al. Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study","volume":"39","author":"G\u00fcnther","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.braindev.2026.104563_bb0015","doi-asserted-by":"crossref","first-page":"1541507","DOI":"10.3389\/fneur.2025.1541507","article-title":"Nusinersen for children with type I spinal muscular atrophy: 4 years\u2019 clinical experience in Turkish cohort","volume":"16","author":"Bekta\u015f","year":"2025","journal-title":"Front Neurol"},{"key":"10.1016\/j.braindev.2026.104563_bb0020","doi-asserted-by":"crossref","first-page":"126153","DOI":"10.1016\/j.talanta.2024.126153","article-title":"A sensitive analytical strategy of oligonucleotide functionalized fluorescent probes for detection of nusinersen sodium in human serum","volume":"275","author":"Zhan","year":"2024","journal-title":"Talanta"},{"issue":"12","key":"10.1016\/j.braindev.2026.104563_bb0025","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s40261-023-01320-4","article-title":"Safety concerns with nusinersen, risdiplam, and onasemnogene abeparvovec in spinal muscular atrophy: a real-world pharmacovigilance study","volume":"43","author":"Zhuang","year":"2023","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.braindev.2026.104563_bb0030","article-title":"Spinraza (nusinersen) prescribing information [internet]. Silver spring (MD): U.S","year":"2023","journal-title":"Food Drug Administrat"},{"issue":"3","key":"10.1016\/j.braindev.2026.104563_bb0035","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00467-019-04405-5","article-title":"Correlation of urine protein\/creatinine ratios to 24-h urinary protein for quantitating proteinuria in children","volume":"35","author":"Huang","year":"2020","journal-title":"Pediatr Nephrol"},{"issue":"1","key":"10.1016\/j.braindev.2026.104563_bb0040","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/mus.27564","article-title":"Stability of serial platelet and urine protein measurements in patients receiving nusinersen for spinal muscular atrophy","volume":"66","author":"Nagarajan","year":"2022","journal-title":"Muscle Nerve"},{"issue":"1","key":"10.1016\/j.braindev.2026.104563_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.70221","article-title":"Safety and efficacy of nusinersen focusing on renal and hematological parameters in spinal muscular atrophy","volume":"15","author":"Bahad\u0131r \u015eenol","year":"2025","journal-title":"Brain Behav"},{"issue":"7","key":"10.1016\/j.braindev.2026.104563_bb0050","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.4103\/NRR.NRR-D-24-00067","article-title":"Insights into spinal muscular atrophy from molecular biomarkers","volume":"20","author":"Xing","year":"2025","journal-title":"Neural Regen Res"},{"issue":"6","key":"10.1016\/j.braindev.2026.104563_bb0055","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1542\/peds.105.6.1242","article-title":"Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel","volume":"105","author":"Hogg","year":"2000","journal-title":"Pediatrics"},{"issue":"0","key":"10.1016\/j.braindev.2026.104563_bb0060","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4038\/jpgim.8117","article-title":"Assessment of the validity of protein-osmolality ratio in a randomly collected urine specimen, in the estimation of proteinuria in children","volume":"3","author":"Dilanthi","year":"2016","journal-title":"J Postgrad Inst Med"},{"issue":"5","key":"10.1016\/j.braindev.2026.104563_bb0065","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s10157-008-0056-3","article-title":"Protein-osmolality ratio for quantification of proteinuria in children","volume":"12","author":"Serdaroglu","year":"2008","journal-title":"Clin Exp Nephrol"},{"issue":"2","key":"10.1016\/j.braindev.2026.104563_bb0070","first-page":"202","article-title":"Osmolalidad urinaria en pacientes con poliquistosis renal: \u00bfmedida o calculada?","volume":"40","author":"Borrego Utiel","year":"2020","journal-title":"Nefrologia (Madr)"},{"issue":"3","key":"10.1016\/j.braindev.2026.104563_bb0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.5144\/0256-4947.2005.215","article-title":"Quantification of proteinuria with urinary protein to osmolality ratios in children with and without renal insufficiency","volume":"25","author":"Hooman","year":"2005","journal-title":"Ann Saudi Med"},{"issue":"9\u201310","key":"10.1016\/j.braindev.2026.104563_bb0080","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.nmd.2007.05.009","article-title":"An expanded version of the hammersmith functional motor scale for SMA II and III patients","volume":"17","author":"O\u2019Hagen","year":"2007","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.braindev.2026.104563_bb0085","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.nmd.2009.11.014","article-title":"The Children\u2019s Hospital of Philadelphia infant test of neuromuscular disorders (CHOP INTEND): test development and reliability","volume":"20","author":"Glanzman","year":"2010","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.braindev.2026.104563_bb0090","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1289\/ehp.7337","article-title":"Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements","volume":"113","author":"Barr","year":"2005","journal-title":"Environ Health Perspect"},{"issue":"5","key":"10.1016\/j.braindev.2026.104563_bb0095","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00467-005-0001-6","article-title":"Urinary creatinine excretion and protein\/creatinine ratios vary by body size and gender in children","volume":"21","author":"Mori","year":"2006","journal-title":"Pediatr Nephrol"},{"issue":"2","key":"10.1016\/j.braindev.2026.104563_bb0100","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0022-3476(05)82881-1","article-title":"Quantitation of proteinuria with urinary protein\/creatinine ratios and random testing with dipsticks in nephrotic children","volume":"116","author":"Abitbol","year":"1990","journal-title":"J Pediatr"},{"issue":"3","key":"10.1016\/j.braindev.2026.104563_bb0105","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/ajcn\/37.3.478","article-title":"Measurement of muscle mass in humans: validity of the 24-hour urinary creatinine method","volume":"37","author":"Heymsfield","year":"1983","journal-title":"Am J Clin Nutr"},{"issue":"9\u201310","key":"10.1016\/j.braindev.2026.104563_bb0110","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1159\/000533173","article-title":"The good, the bad, and the serum creatinine: exploring the effect of muscle mass and nutrition","volume":"52","author":"De Rosa","year":"2023","journal-title":"Blood Purif"},{"issue":"2","key":"10.1016\/j.braindev.2026.104563_bb0115","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/mus.27760","article-title":"A longitudinal study of creatine kinase and creatinine levels in Duchenne muscular dystrophy","volume":"67","author":"Zygmunt","year":"2023","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.braindev.2026.104563_bb0120","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejpn.2025.10.001","article-title":"Value of creatine kinase and creatinine as biomarkers in nusinersen-treated children with spinal muscular atrophy","volume":"59","author":"Ren","year":"2025","journal-title":"Eur J Paediatr Neurol"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760426000641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760426000641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T22:34:38Z","timestamp":1785969278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760426000641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0387760426000641"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2026.104563","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urine protein\/osmolality and creatinine\/osmolality ratios for assessing proteinuria and motor function in children with spinal muscular atrophy","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2026.104563","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Japanese Society of Child Neurology. Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104563"}}